Nephrology:
the physiologist’s specialty
Nephrology is the physiologist’s specialty — acid–base, fluid and electrolytes, the deranged internal milieu — and a career built on three things at once: hospital consults, longitudinal CKD, transplant, and hypertension clinic, and the year-round rhythm of dialysis. It asks two hard things: a comparatively modest paycheck for a heavy, weekend-heavy workload, and an economics that runs on dialysis — panel management, medical directorships, and facility ownership — rather than on procedures or clinic volume. It is also one of the most IMG-central fellowships in medicine. Understand the work and the trades, and the rest follows. Here is the honest picture.
At a glance
Every specialty on this site involves a trade, and nephrology’s is unusually layered. You get deep physiology, years-long continuity with the same patients, durable demand, and a genuine path to practice and dialysis ownership. You give up a light schedule and top-of-market pay: the call is among the heavier in the outpatient-leaning half of internal medicine, and base compensation is modest for the effort. The specialty is also easy to enter and hard to fill — a recruitment gap driven by that pay-and-lifestyle trade, not a signal that the field is a lesser choice. For the internist who loves the physiology and the long game, it is an undervalued, welcoming field.
| Dimension | Where nephrology lands |
|---|---|
| Training after IM residency | 2-year ACGME fellowship (ABIM board-eligible); an optional 3rd research year is common; 1-year ACGME add-ons now exist for transplant and, via a dual pathway, critical care |
| Competitiveness | Among the least competitive IM fellowships to enter: 66.5% of 501 certified positions filled, and 93% of applicants who preferred nephrology matched into it (2026 appointment-year Match, NRMP/ASN). Most committed applicants match somewhere1 |
| Typical compensation | Among the more modestly paid IM subspecialties relative to workload — ASN’s 2024 fellow survey put the median first-job base at $240,0002. The real economic levers are dialysis (panel management, directorships, ownership), not clinic volume or procedures |
| Practice setting | A distinctive three-part rhythm: hospital consults, longitudinal CKD/transplant/hypertension clinic, and recurring dialysis-unit rounding |
| Procedural vs cognitive | Strongly cognitive and consultative; procedures (dialysis catheters, kidney biopsy, POCUS; access work for interventionalists) are real but are not the economic engine |
| Call burden | Among the heavier in outpatient-leaning IM — dialysis runs year-round, so weekend and holiday rounding is structural, alongside frequent AKI, electrolyte, and dialysis consults |
| Workforce outlook | Durable demand from rising CKD burden; HRSA projects nephrology at 85% adequacy in 2038, with far worse rural access3 |
What it involves
Nephrology is the internal-medicine subspecialty of the kidney and its systemic reach, and its scope is unusually broad for a “single-organ” field: chronic kidney disease (CKD), end-stage kidney disease and dialysis, acute kidney injury (AKI), fluid, electrolyte, and acid–base disorders, hypertension, glomerular disease and vasculitis, the medical management of kidney transplantation, and critical-care nephrology with continuous renal replacement therapy. It is the specialty other physicians call when the internal milieu is deranged — a sodium of 108, a refractory metabolic acidosis, hyperkalemia on the monitor. The work is fundamentally consultative and cognitive, with a rhythm few fields share: inpatient consultation, longitudinal outpatient clinic, and a distinctive third domain — dialysis-unit rounding, recurring relationship-driven care to a panel of dialysis patients over years.
A day in the life
A community nephrologist's day often starts before clinic, on the dialysis unit: rounding on a panel of in-center patients, adjusting dry weights and dialysis prescriptions, reviewing labs and access, and catching problems before they become admissions. From there the day splits between hospital consults — an AKI in the ICU needing CRRT, a severe hyponatremia, a hyperkalemia — and an afternoon CKD/transplant/hypertension clinic, where the work is titration, education, transplant referral, and planning the next stage of a years-long relationship. Threaded through it is coordination: with dialysis-unit staff, transplant centers, vascular access, primary care, and families. Community nephrologists often add “windshield time” driving between hospitals and units. It is cognitive, longitudinal, and logistically busy — and it looks different on a transplant or academic service (below).
The training pathway
After a three-year IM residency and ABIM internal medicine certification, nephrology fellowship is 24 months of ACGME-accredited training, at least 12 clinical, with a continuity clinic throughout — inpatient consults, ICU nephrology, transplant, in-center and home dialysis, glomerular disease, hypertension, and kidney pathology — leading to the ABIM Nephrology exam45. A third research year, often on an NIH training grant, is common for physician-scientist tracks.
Sub-tracks and niches
Most niches are built within or after the standard two years. Two carry formal accreditation; the rest are shaped on the job.
| Sub-track / niche | Extra training or credential | What it looks like |
|---|---|---|
| General / community nephrology | None beyond fellowship | The largest group: clinic, hospital consults, and dialysis — the base from which ownership and directorship roles grow |
| Transplant nephrology | 1-year fellowship, ACGME-accredited since September 30, 20256 | Medical management of transplant candidates and recipients. It does not currently confer a separate ABIM certificate; a future certificate was only discussed in fall 20257 |
| Interventional nephrology | Non-ACGME; ASDIN certification | Dialysis-access work — tunneled catheters, fistula/graft angioplasty and thrombectomy. No separate ABIM board; adds procedural skill and income |
| Critical-care nephrology | An additional ACGME critical-care year → ABIM Critical Care Medicine (dual boards) | ICU-based practice with CRRT; the single most common further-training path in ASN’s 2024 fellow survey2 |
| Onconephrology & glomerular disease | Focused fellowship or on-the-job | Fast-growing intersections — kidney disease in cancer care, and the glomerular/vasculitis niche — usually without a separate board |
| Home dialysis & conservative management | Focused experience | Peritoneal and home hemodialysis programs, and supportive/palliative nephrology for advanced-CKD patients who choose not to dialyze |
One boundary worth stating plainly: pediatric nephrology is a separate path, entered through a pediatrics residency and a three-year ACGME pediatric nephrology fellowship certified by the American Board of Pediatrics — not a route from adult internal medicine.
Competitiveness
Nephrology is, by the numbers, one of the least competitive fellowships in internal medicine to enter and among the harder to fill — but frame it honestly. In the 2026 appointment-year Match, nephrology offered 501 positions across 186 tracks; 333 candidates matched, filling 66.5%, and only 89 tracks (48%) filled completely; the applicant-to-position ratio was 0.68. Of the 341 candidates who preferred nephrology, 316 (93%) matched into it1. In plain terms: if you genuinely want this field, you can almost certainly have it — though not automatically at a specific sought-after program. The decade’s trend is a long decline with a fragile rebound: fill rose to 73% in the 2025 appointment year before slipping back to 66.5%8. This is a recruitment problem, not a demand problem — what has thinned is the number of US trainees choosing the field, for the pay-and-lifestyle reasons this page keeps returning to.
| 2026 appointment year | 2025 appointment year | |
|---|---|---|
| Certified positions | 501 | 496 |
| Positions filled | 333 (66.5%) | 362 (73%) |
| Training tracks offered | 186 | 178 |
| Tracks filled completely | 89 (48%) | 103 (58%) |
The contrast with the procedural fellowships is stark, from the same 2026 report: cardiology filled about 100% of positions, gastroenterology 99.5%, pulmonary/critical care 98.8%. Nephrology, at 66.5%, sits near the bottom of the IM subspecialties — above only infectious diseases (60.9%), advanced heart failure and transplant cardiology (59.8%), and geriatric medicine (38.9%)9. Read it as a mentor would: the accessibility is an opportunity, but only for the right person. Present the work and the fit first — do not choose nephrology as a fallback because it is easy to match. If a renal rotation, an acid–base puzzle, or a hard consult once lit a spark in you, this field will reward you for a career; if it did not, the easy match is not a reason on its own.
Skills & personality
Nephrology is widely regarded within medicine as the physiologist’s specialty, and the reputation is earned. Diagnosis turns on reasoning through feedback loops, acid–base chemistry, and fluid and electrolyte balance rather than on imaging or a procedure log. If you were the resident who lit up untangling a refractory hyponatremia, a wide anion gap, or an unexplained hypertension, that is part of the daily texture — alongside the longitudinal chronic-disease work that is most of it. It rewards the diagnostic detective who is drawn to the sickest, most metabolically complex, multi-organ patients, and who is comfortable being the consultant who advises rather than the proceduralist who fixes.
The field also rewards a specific temperament for continuity: nephrologists care for dialysis and transplant patients for years, and the relationships run deep. That calls for strong communication and patience — much of the work is education, titration, goals-of-care conversation, and coordination across a patient’s whole care team, over a long horizon, with progress measured in slowed decline rather than dramatic cure.
Who tends to be unhappy? Physicians who crave high procedural volume and immediate, hands-on wins; those who want a light, predictable schedule and cannot accept year-round weekend dialysis rounding; and anyone for whom income relative to training length is the primary driver. The intellectual and relational pull has to be real here, because neither the paycheck nor the call schedule will carry you.
Lifestyle & the schedule
Nephrology carries a reputation — largely deserved — for a heavy and unpredictable workload, and the call burden is among the specialty’s most-cited drawbacks. Dialysis patients need care every day of the year, so nephrologists round on units on weekends and holidays as a matter of course; layered on top is a busy consult service (AKI, hyperkalemia, severe hyponatremia, dialysis emergencies) that pages at all hours, plus “windshield time” between hospitals and units and a high administrative load. But the schedule varies enormously by setting, and that variation is worth seeing concretely:
- Employed / hospital nephrology: clinic plus hospital consults, dialysis rounds shared across a group, and a defined call rotation — the most contained version, though weekend dialysis coverage still rotates to you.
- Private single-specialty group: the fullest three-part life — clinic, consults across several hospitals, a large dialysis panel, medical-director duties, and more weekend and windshield time; the trade for the ownership economics below.
- Transplant nephrology: concentrated at transplant centers — inpatient-heavy service weeks, recipient and donor clinics, and transplant call, with less general dialysis rounding.
- Academic nephrology: protected research/teaching time against attending service weeks, subspecialty clinics (glomerular, onconephrology), and a lighter dialysis-ownership dimension.
On burnout, nephrology tends to sit in the middle-to-high range depending on the survey, and ASN’s fellow surveys repeatedly identify lifestyle and call frequency as leading deterrents to recruitment2. The encouraging counter-trend: advanced-practice-provider-supported models, telehealth, consolidated call, and reduced windshield time are increasingly on offer, and are worth scrutinizing closely when you compare programs and first jobs.
Compensation & dialysis economics
Nephrology’s central paradox is a heavy workload paired with comparatively modest base pay. The cleanest anchor comes from the specialty’s own society: ASN’s 2024 fellow survey put the median first-job base for graduating adult nephrologists at $240,000 (transplant fellows $250,000, pediatric $190,000), and fellows increasingly cite compensation as a leading reason they would not recommend the field2. The large national surveys place nephrology in the lower-to-middle band of IM subspecialties — the Doximity 2025 report (2024 data) put the all-experience average at $367,425, above general internal medicine but well below the procedural fields, and well above the ASN first-job base above (start low, climb with experience)101112. But base clinical pay is only half the story — and in nephrology the other half is unusual, because the field’s economics are driven by dialysis, not by procedures or clinic volume.
The income layers, separated
A nephrologist’s earnings are built in distinct layers, and they carry very different risks and obligations:
- Clinical base salary — employed pay for clinic and consult work, plus panel management under the Monthly Capitation Payment: Medicare pays a bundled monthly amount per outpatient dialysis patient, tiered by monthly face-to-face visits and patient age (42 CFR 414.314; CPT 90951–90970), so professional income scales with panel size, not procedure counts13.
- Medical-directorship stipend — a dialysis facility pays a nephrologist, at “fair market value,” to serve as medical director (quality oversight and regulatory duties). It is an annual role with real availability obligations, and by law the stipend must be FMV and cannot be tied to the volume of patients you refer.
- Joint-venture equity — a minority ownership stake in a dialysis facility (usually a joint venture with one of the large chains) that shares in facility profits. This is capital at risk, not salary.
- Independent facility ownership — rare and capital-intensive, the fullest form of the ownership model.
Because facility profits sit on top of clinical income, ownership is widely regarded as the largest single lever on a nephrologist’s earnings. The one rigorous, peer-reviewed window onto this is Xia and colleagues’ 2025 analysis in JAMA Health Forum: the two largest chains’ share of freestanding facilities rose from 59.1% (2005) to 77.1% (2019); facilities with any physician owner rose from 11.4% to 29.1%; and physician joint ventures with the large chains grew from 4.6% to 23.7%. Crucially, market structure tracked with dollars — in single-large-chain markets, medical-director compensation was $564.56 higher per patient and commercial hemodialysis prices $495.08 higher14. That is the evidence that ownership and market structure, not clinic RVUs, drive nephrology’s financial upside.
Intellectual scope
If the paycheck and the call are the field’s weaknesses, the intellectual life is its glory — and it is why nephrologists who chose the field for the physiology tend to stay glad they did. Nephrology is arguably the purest expression of applied physiology left in clinical medicine: acid–base and electrolyte reasoning, feedback loops, and the kind of puzzle that only resolves once you assemble the clues. Because the kidney touches every organ system, the differential is wide, and the work spans the acute and the lifelong.
The continuity is its own reward: much of nephrology is the long game — slowing CKD progression, protecting a transplant, keeping a dialysis patient whole for years. And the science is moving: academic nephrology carries strong NIH-funded research traditions across CKD, glomerular immunology, hypertension, and transplant tolerance, and newer frontiers — onconephrology, home dialysis, glomerular disease, kidney bioengineering, and the extension of SGLT2 and related therapies into kidney protection — keep the field intellectually restless. For those who like to teach, few specialties teach physiology better.
Pathways & career arc
The employment models sort into four: private-practice single-specialty groups (often the highest-earning, precisely because they carry dialysis directorship and joint-venture income), dialysis-organization-affiliated practices, hospital-employed roles, and academic nephrology. Beyond the clinic, the field opens onto dialysis-organization medical leadership, home-dialysis and CKD program direction, and industry and research roles across the kidney-care pipeline.
Demand is strong and durable, and the drivers are demographic: more than one in seven US adults — about 35.5 million people — are estimated to have CKD, and as many as nine in ten do not know it15. On the supply side, HRSA’s December 2025 projections put nephrology at 85% adequacy in 2038 — a moderate national shortfall, but far worse where it matters for access: the same brief projects, across all physician specialties, just 42% adequacy in nonmetro areas versus 95% in metro3. That geographic maldistribution — urban markets closer to saturated, many rural and underserved communities short — is the defining feature of the nephrology job market, and it is where the openings, incentives, and visa-waiver opportunities concentrate.
The career arc, honestly. Nephrology is a durable, cognitive career: no physical procedural clock runs out on you, and the work scales into telemedicine and APP-supported models that can lighten call in later years. The distinctive arc is economic — the first years build clinical volume and a dialysis panel, and the directorship-and-ownership layer accrues over time, so a nephrologist’s income and autonomy often grow substantially a decade in. Niches evolve too (transplant, onconephrology, home dialysis, glomerular disease, critical care), and academic, industry, and dialysis-organization leadership are accessible second acts. Job security is excellent throughout — within a compensation band the payment system, not scarcity, sets.
Choosing a fellowship & first job
Nephrology asks you to choose twice: first a fellowship, then a first job — and in this field, strong demand does not guarantee a good first contract. The through-line is the same: decide what matters for your direction, evaluate the program or group against it, and negotiate the terms.
Choosing the fellowship. Weigh clinical volume and breadth (will you graduate confident across consults, dialysis, transplant, and glomerular disease?), transplant and critical-care exposure if those draw you, research support, geography, and — for IMGs — documented visa sponsorship (below).
Choosing the first job. Because demand is high, it is easy to sign a job that is busy but not good. Normalize competing offers to the same terms and get the details in writing:
- The clinical and call model: the call pool size and rotation, weekend dialysis coverage, how many hospitals and dialysis units you would cover (windshield time), and APP support.
- The path to the economics: whether there is a real partnership track, a medical-directorship opportunity (and its duties), and a joint-venture ownership path — with timelines, buy-in terms, and how it is governed (see the cautions above).
- The contract: base versus productivity, restrictive covenants / non-compete scope, without-cause termination, malpractice and tail, and who actually employs you.
IMG considerations
If you are an international medical graduate, this is among the best news on the site. Nephrology is one of the most IMG-central fellowships in all of US medicine — not a consolation prize, but a field where IMGs have been the majority of trainees for well over a decade. In the 2026 appointment-year Match, non-US-citizen IMGs took 133 of 333 matched positions (about 40%) and US-citizen IMGs another 61 (about 18%) — combined, roughly 58% of the matched class1. With a third of positions unfilled and more than half of tracks not filling completely, the door is genuinely, structurally open. (Two companion analyses take up the wider questions: whether international graduates take US graduates' spots, and the H-1B for physicians in training; practical planning lives on the IMG guide.)
Frame it honestly, though: the hard parts are not the Match; they are visa sponsorship and the compensation-and-workload trade — and the two visa stages must be kept separate. For training, J-1 sponsorship through ECFMG’s Exchange Visitor Sponsorship Program is the standard route, and program-by-program H-1B policies vary — confirm each program’s stance early16. For employment after training, the J-1 two-year home-residency requirement is typically navigated through a Conrad 30 or similar waiver — but a waiver job is not automatic: the employer must place you in a designated shortage area and sponsor the waiver, and the eligible job location must be verified17. Where nephrology genuinely aligns with the IMG path is that its deepest need sits in exactly those underserved places, so waiver placements are relatively abundant — but still verified job by job, not assumed.
Eligibility follows the usual package: a valid ECFMG certificate, completion of a US ACGME-accredited IM residency, ABIM internal medicine certification, and the standard application materials — with evidence of sustained, genuine interest in kidney disease the most persuasive element. US clinical experience and a finishable project (a CKD or dialysis QI effort, a glomerular or onconephrology case series, an AKI outcomes review) strengthen an IMG application meaningfully. For an IM-bound IMG who loves physiology and is willing to serve where the need is greatest, nephrology is one of the surest routes to a US subspecialty career — and to an underserved-area waiver placement — and it deserves a place near the very top of the list.
Bottom line
Consider nephrology if you love physiology, acid–base, and fluid-and-electrolyte reasoning and the longitudinal chronic-disease work that is most of the job; you value years-long continuity and the long game; you want durable demand, excellent job security, and a genuine path to practice and dialysis ownership; or you are an IMG seeking an attainable, visa-navigable subspecialty where you would be central to the workforce, not on its margins.
It may not fit if income relative to training length and workload is a primary driver; if you want high procedural volume and immediate, hands-on wins; if you need a light, predictable schedule and cannot accept year-round weekend dialysis rounding; or if you have no interest in the dialysis-unit and ownership side that, more than clinic volume, defines the field’s economics.
A last mentor’s note: the accessibility of nephrology is real, and it is not a trap — it is a recruitment gap that a committed physiologist can walk straight through into a durable, meaningful career. The nephrologists who chose the field for the physiology and the continuity tend to say the trade was worth it. Find one at your program, round with them on a dialysis unit for a day, and ask why they love it despite the call — and, when the offers come, evaluate the job’s call, coverage, and ownership path as carefully as you chose the field.
References
- Pivert, K. (2025). First look: AY 2026 nephrology Match. ASN Data. https://data.asn-online.org/posts/ay_2026_match/ 501 positions across 186 tracks; 333 matched (66.5% fill); 89 tracks (48%) filled completely; applicant-to-position ratio 0.68. Of 341 candidates preferring nephrology, 316 (93%) matched into it. Matched class: 133 non-US-citizen IMG (~40%), 61 US-citizen IMG (~18%). ↩1 ↩2 ↩3
- American Society of Nephrology. (2024). 2024 ASN nephrology fellow survey report (11th annual). https://data.asn-online.org/posts/2024_fellow_survey/ Median first-job base salary for graduating adult nephrologists $240,000 (up 4%); transplant fellows $250,000; pediatric $190,000. Critical-care was the most common further-training path. Compensation entered the top five factors rated "extremely important" for the first time since 2021. Self-reported by graduating fellows. ↩1 ↩2 ↩3 ↩4
- HRSA National Center for Health Workforce Analysis. (2025). Physician workforce: Projections, 2023–2038. https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/physicians-projections-factsheet.pdf December 2025. Nephrology projected at 85% adequacy in 2038 (a 15% shortfall). Separately, and across ALL physician specialties (not nephrology alone), the brief projects 42% adequacy in nonmetro areas versus 95% in metro. Projections, not guarantees. ↩1 ↩2
- Accreditation Council for Graduate Medical Education. (2026). Program requirements for graduate medical education in nephrology. https://www.acgme.org/globalassets/pfassets/programrequirements/2026-prs/148_nephrology_2026.pdf 24-month fellowship, at least 12 clinical months, continuity clinic throughout. ↩
- American Board of Internal Medicine. (n.d.). Nephrology certification policies. https://www.abim.org/certification/policies/internal-medicine-subspecialty-policies/nephrology/ General nephrology certification; transplant competence is assessed within it — no separate transplant-nephrology certificate. ↩
- Accreditation Council for Graduate Medical Education. (2025). Program requirements for graduate medical education in transplant nephrology. https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/137_transplantnephrology_9.30.2025.pdf New one-year fellowship requirements approved effective September 30, 2025, within an ACGME nephrology program. ↩
- American Board of Internal Medicine. (2025). Nephrology Board meeting summary, Fall 2025. https://blog.abim.org/nephrology-board-meeting-summary-fall-2025/ Feasibility of a future transplant-nephrology certificate was discussed, not established. ↩
- Pivert, K. (2025). First look: AY 2025 nephrology Match. ASN Data. https://data.asn-online.org/posts/ay_2025_match/ Prior cycle: 496 positions, 362 matched (73% fill), 103 of 178 tracks (58%) filled completely. ↩
- National Resident Matching Program. (2025). Results and data: Specialties Matching Service, Medicine and Pediatric Specialties, 2026 appointment year. https://www.nrmp.org/match-data/ Comparison fills across IM subspecialties (matches conducted December 2025). Nephrology’s figures on this page follow ASN’s analysis of the NRMP data. ↩
- Doximity. (2025). Physician compensation report 2025 (2024 data). https://www.doximity.com/reports/physician-compensation-report/2025 Self-reported/modeled survey (over 37,000 responses, 2024 data). Nephrology all-experience average $367,425 — above general internal medicine ($326,116), and well above the ASN first-job base, reflecting the start-low, climb-with-experience pattern. ↩
- Medscape. (2024–2026). Nephrologist compensation reports. Self-reported survey; subscription access required, not reproduced here. Places nephrology in the lower-to-middle band. ↩
- MGMA. (2025). Provider compensation data. Subscription-gated, not reproduced here. Directional benchmark only. ↩
- Centers for Medicare & Medicaid Services. (n.d.). 42 CFR 414.314 — Monthly capitation payment method for physician dialysis services. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-414/subpart-F/section-414.314 A bundled monthly payment per outpatient dialysis patient, tiered by the number of monthly face-to-face visits and by patient age (CPT 90951–90970) — so professional income scales with panel size, not procedure counts. ↩
- Xia, Y., et al. (2025). Financial ties, market structure, commercial prices, and medical director compensation in dialysis. JAMA Health Forum. https://pmc.ncbi.nlm.nih.gov/articles/PMC12177639/ PMID 40531510. The two largest chains’ share of freestanding facilities rose from 59.1% (2005) to 77.1% (2019); by 2019, 32.5% of the population lived in a hospital service area whose only dialysis was one of those two chains. Facilities with any physician owner rose from 11.4% to 29.1%; physician joint ventures with the large chains grew from 4.6% to 23.7%. In single-large-chain markets, medical-director compensation was $564.56 higher per patient and commercial hemodialysis prices $495.08 higher. ↩
- Centers for Disease Control and Prevention. (n.d.). Chronic kidney disease in the United States. https://www.cdc.gov/kidney-disease/php/data-research/ More than 1 in 7 US adults (about 35.5 million) are estimated to have CKD, and about 9 in 10 do not know it. ↩
- Educational Commission for Foreign Medical Graduates. (n.d.). Exchange Visitor Sponsorship Program (J-1): General information. https://www.ecfmg.org/evsp/applying-general.html ↩
- U.S. Citizenship and Immigration Services. (n.d.). Conrad 30 Waiver Program. https://www.uscis.gov/working-in-the-united-states/students-and-exchange-visitors/conrad-30-waiver-program Each state may sponsor up to 30 J-1 physicians a year (specialists included) in exchange for a three-year commitment in a designated Health Professional Shortage Area or Medically Underserved Area; the employer must sponsor the waiver and the eligible job location must be verified. ↩
- Restriction on Entry of Certain Nonimmigrant Workers, Proclamation No. 10973. (2025, September 24). Federal Register. https://www.federalregister.gov/documents/2025/09/24/2025-18601/restriction-on-entry-of-certain-nonimmigrant-workers Signed September 19, 2025; effective September 21, 2025. Imposes a $100,000 payment requirement on certain new H-1B petitions for beneficiaries outside the United States, with national-interest exemptions and a twelve-month sunset absent extension. ↩
- U.S. Citizenship and Immigration Services. (2025). H-1B: Frequently asked questions on the September 2025 proclamation. https://www.uscis.gov/newsroom/alerts/h-1b-faq USCIS guidance that the payment requirement applies to new petitions for beneficiaries outside the United States without a valid H-1B visa, and does not reach previously issued visas, earlier-filed petitions, renewals, or change-of-status, amendment, and extension petitions for people already in the country. ↩
- State of California v. Mullin, No. 1:25-cv-13829-LTS (D. Mass. June 8, 2026) (Sorokin, J.), appeal docketed, No. 26-01699 (1st Cir. 2026). https://www.fragomen.com/insights/united-states-district-court-temporarily-stays-order-vacating-dollar100000-h-1b-fee.html The district court vacated the payment requirement on June 8, 2026 as an unlawful tax and Administrative Procedure Act violation, then temporarily stayed its own order on June 12, 2026 pending appeal; the government appealed to the First Circuit. The requirement therefore remains operational for affected petitions at this writing. A fast-moving matter — verify current status before relying. ↩
- American Medical Association. (2025). AMA urges DHS to exempt physicians from the new $100,000 H-1B fee. https://www.ama-assn.org/press-center/ama-press-releases/ama-urges-dhs-exempt-physicians-new-100000-h-1b-visa-fee ↩
Figures here are survey-, administrative-, and projection-based and shift year to year; the ASN starting salaries are self-reported by graduating fellows; the large compensation surveys use differing methods, are read directionally, and several are subscription-gated; dialysis directorship and ownership income is set at “fair market value” and largely undisclosed; and the visa landscape is in active flux and litigation. Verify against the primary source before relying on any single figure for a career, contract, business, or immigration decision. This page is educational and is not career, financial, business, immigration, or legal advice.